Formulation and stability study of hydroxychloroquine sulfate oral suspensions-Reference-Cited by-同舟云学术

Formulation and stability study of hydroxychloroquine sulfate oral suspensions

Published:2021-01-17 Issue:3 Volume:26 Page:328-334
ISSN:1083-7450
Container-title:Pharmaceutical Development and Technology
language:en
Short-container-title:Pharmaceutical Development and Technology

Author:

El Mershati Sarah¹,Thouvenin Agathe¹^ORCID,Secretan Philippe-Henri¹,De Lonlay Pascale²³,Tuchmann-Durand Caroline⁴,Cisternino Salvatore¹⁵,Schlatter Joël¹

Affiliation:

1. Department of Pharmacy, Necker-Enfants Malades University Hospital, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France

2. Reference Center for Inherited Metabolic Diseases, Necker-Enfants Malades University Hospital, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France

3. INSERM, Paris, France

4. Imagine Institut des Maladies Génétiques, Paris, France and Department of Biotherapy, Necker-Enfants Malades University Hospital, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France

5. Faculté de Pharmacie, Université de Paris, Paris, France

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/10837450.2021.1871918

Reference26 articles.

1. New use for an old treatment: Hydroxychloroquine as a potential treatment for systemic vasculitis

2. EMA: Annex to the European Commission guideline on ‘Excipients in the labelling and package leaflet of medicinal products for human use’ (SANTE-2017-11668): European Medicines Agency; [accessed 2020 Aug 07]. https://www.ema.europa.eu/en/documents/scientific-guideline/annex-european-commission-guideline-excipients-labelling-package-leaflet-medicinal-products-human_en.pdf.

3. EMA: ICH Topic Q1A(R2): stability testing of new drug substances and products: European Medicines Agency; [accessed 2020 Aug 07]. https://www.ema.europa.eu/en/documents/scientific-guideline/ich-q-1-r2-stability-testing-new-drug-substances-products-step-5_en.pdf.

4. Hydroxychloroquine Reverses Platelet Activation Induced by Human IgG Antiphospholipid Antibodies

5. European Pharmacopoeia 8.0. 2013. Efficacy of antimicrobial preservation 01/2011:50103. EDQM Council of Europe 8th edition, Strasbourg, France, 600–601.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hydroxychloroquine sulfate: A novel treatment for lipin-1 deficiency?;Biomedicine & Pharmacotherapy;2023-07